Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Founder of Portola Pharmaceuticals, Inc., Calistoga Pharmaceuticals, Inc. and Incline Therapeutics, Inc., James N. Topper is an entrepreneur and businessperson who has been the head of 5 different companies and is Chairman of AnaptysBio, Inc., Chairman & Chief Executive Officer of Frazier Lifesciences Acquisition Corp., Member-Observer Board at Alcresta Therapeutics, Inc., Chairman at Intradigm Corp. and Managing General Partner at Frazier Management LLC.

He is also Clinical Assistant Professor-Medicine at Stanford University and Member-Observer Board at Sojournix, Inc. and on the board of 9 other companies.

In his past career James N. Topper held the position of Executive Chairman of Arŕte Therapeutics, Inc., Chairman at Calistoga Pharmaceuticals, Inc., Head-Cardiovascular Research & Development at COR Therapeutics, Inc., Head-Cardiovascular Research & Development at Millennium Pharmaceuticals, Inc., Managing Member at FHM Life Sciences VIII LLC, Independent Director at Portola Pharmaceuticals, Inc. and Director at Incline Therapeutics, Inc.

He received a doctorate and a graduate degree from Stanford University School of Medicine and an undergraduate degree from the University of Michigan.


Current positions of James N. Topper 
NameTitle Since
AnaptysBio, Inc.
(Biotechnology & Medical Research)
Chairman -
Frazier Lifesciences Acquisition Corporation
(Investment Holding Companies)
Chairman & Chief Executive Officer 2003
Alpine Immune Sciences, Inc.
(Biotechnology & Medical Research)
Independent Director 2016
Intradigm Corp. Chairman 2006
Millendo Therapeutics US, Inc. Director 2012
Amunix, Inc. Director 2018
Alcresta Therapeutics, Inc. Member-Observer Board -
Merganser Biotech, Inc. Director -
Entasis Therapeutics, Inc. Independent Director 2016
Amunix Pharmaceuticals, Inc. Director -
Lassen Therapeutics LLC Director -
Seraxis Holdings, Inc. Director -
Enlaza Therapeutics, Inc. Director -
Frazier Management LLC Managing General Partner 2003
Stanford University Clinical Assistant Professor-Medicine -
Sojournix, Inc. Member-Observer Board -


Holdings of James N. Topper 
NameEquities%Valuation
AnaptysBio, Inc. (ANAB)
(Biotechnology & Medical Research)
1,061,3243.87%34,917,560 USD
Gritstone bio, Inc. (GRTS)
(Pharmaceuticals)
61,3070.095%673,764 USD
Arcutis Biotherapeutics, Inc. (ARQT)
(Biotechnology & Medical Research)
30,6470.061%649,103 USD
Phathom Pharmaceuticals, Inc. (PHAT)
(Biotechnology & Medical Research)
16,5080.053%388,433 USD
Aptinyx Inc. (APTX)
(Pharmaceuticals)
4,9760.0073%11,146 USD
Allena Pharmaceuticals, Inc. (ALNA)
(Biotechnology & Medical Research)
00.0000%0 USD
Alpine Immune Sciences, Inc. (ALPN)
(Biotechnology & Medical Research)
00.0000%0 USD


James N. Topper: Personal Network 
Most Read News 
11/15PATRICK DRAHI : Altice founder Drahi seeks bigger stake in Britain's BT - sources
RE
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/15ELON MUSK : Analysis-Musk's $6 billion Tesla stock haul has charity circuit buzzing
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
11/17HENRIK FISKER : Fisker unveils electric SUVs to beat Tesla over driving range
RE
11/16ELON MUSK : Tesla's Musk sells another 934,000 shares to pay taxes after exercising options - filing
RE
11/15WARREN BUFFETT : Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company
RE
11/16TED ROGERS : Rogers names Staffieri interim CEO as chair stamps authority after family feud
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/15ELON MUSK : Tesla's Musk sells $930 mln in shares to cover stock option tax - filings
RE
More news


© 2021 People and Ownership :   
James N. Topper : Connections